Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Coma Diagnosis and Treatment Companies

ID: MRFR/Pharma/3555-HCR
120 Pages
Vikita Thakur
Last Updated: February 16, 2025
Diagnosis and treatment of coma involve a complex interplay of medical expertise, technological advancements, and specialized care. Several companies play a crucial role in this field, contributing to the development of innovative technologies, diagnostic tools, and treatment modalities.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Coma Diagnosis and Treatment Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)7.62%
2024 Market Size$ 5.88 Billion
2025 Market Size$ 6.32 Billion
2035 Market Size$ 13.18 Billion
Key Players
Medtronic
Siemens Healthineers
GE Healthcare
Philips Healthcare
Baxter International
Abbott Laboratories
Opportunities
  • Emerging Research and Clinical Trials
  • Rising Incidence of Neurological Disorders
  • Technological Innovations in Diagnostic Tools

Top Industry Leaders in the Coma Diagnosis and Treatment Market

Coma Diagnosis and Treatment Key Companies
ย 
Latest Coma Diagnosis and Treatment Companies Update

Siemens Healthineers Launched the Lumify, a portable and affordable ultrasound system, potentially improving access to brain scans for coma diagnosis in resource-limited settings.

GE Healthcare Developed the Discovery MR 750w scanner with advanced neuroimaging capabilities, offering enhanced detection of subtle brain abnormalities in comatose patients.

Philips Healthcare Introduced the BioSuite ICX monitor with integrated neuromonitoring features, allowing for continuous and comprehensive monitoring of comatose patients.

Brain Resource Company Received FDA approval for its NeuroPace RNS System, a brain stimulation device for treatment of drug-resistant epilepsy, which can have application in comas caused by seizure activity.

List of Coma Diagnosis and Treatment Key Companies in the Market

  • Fujifilm Holdings (Japan)
  • GE Healthcare (U.S.)
  • Siemens Healthcare(U.S.)
  • Philips Healthcare (U.S.)
  • Shimadzu Corporation (Japan)
  • Toshiba Medical Systems Corporation (Japan)
  • Carestream Health (U.S.)
  • Nihon Kohden Corporation (Japan)
  • Electrical Geodesics Inc. (U.S.)
  • Masimo Corporation (U.S.)
  • Hologic (U.S.)
  • Esaote (Italy)